| Revenue | SEK 2,4M | -16% |
| EBITDA | SEK -23K | -2200% |
| Net profit | SEK -78K | -73% |
| Total assets | SEK 563K | +1% |
| Equity | SEK -223K | -55% |
| Employees | 0 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 783 | 2 921 | 3 093 | 3 119 | 2 775 | 2 898 | 2 446 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 265 | 255 | −9 | −34 | 66 | 42 | 81 | −1 | −23 |
| Depreciation & amort. | −160 | −161 | −161 | −6 | −6 | −6 | −6 | −0 | −0 |
| EBIT | 105 | 94 | −170 | −40 | 60 | 36 | 75 | −1 | −23 |
| Net financials | −52 | −43 | −33 | −28 | −24 | −15 | −15 | −44 | −55 |
| Profit before tax | 54 | 52 | −203 | −68 | 36 | 20 | 60 | −45 | −78 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 54 | 52 | −203 | −68 | 36 | 20 | 60 | −45 | −78 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 194 | 1 191 | 768 | 696 | 518 | 539 | 560 | 557 | 563 |
| Equity | 54 | 56 | −148 | −216 | −179 | −159 | −100 | −144 | −223 |
| Long-term debt | 320 | 240 | 180 | 115 | 56 | 0 | 150 | 139 | 130 |
| Short-term debt | 820 | 895 | 736 | 797 | 642 | 698 | 510 | 562 | 656 |
| Total debt | 1 140 | 1 135 | 916 | 912 | 698 | 698 | 660 | 701 | 786 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Anders Andersson | Audit | 0 companies |
| Carl Håkan Drugge | Deputy Board Member | 0 companies |
| Carl Patrick Drugge | Board of Directors | 0 companies |